The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials.

Stem Cell Res Ther · 2026 · PMC13072649 · PMID 41787572

Europe PMC DOI

hedged sentences

0.0300

closest p · 0.6× alpha

0.0300

boldest claim

The sentences

marginally significantp = 0.03actually significant

BM-MSCs showed a marginally significant effect (OR = 1.50, p = 0.03), while UC-MSCs did not reach significance (Figure S13).

also in 26,082 other papers

did not reach statistical significanceno p-value reported

Low-dose and high-dose regimens did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.